Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 INDUSTRIAL INSIGHTS:
4.4 CONCLUSION
5 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING USAGE OF TARGETED SEQUENCING METHODS
6.1.2 INCREASE IN THE ADOPTION OF NEXT GENERATION SEQUENCING
6.1.3 INCREASING DIAGNOSTICS APPLICATIONS OF WHOLE EXOME SEQUENCING
6.1.4 INCREASE TREND TOWARD PERSONALIZED MEDICATION
6.2 RESTRAINTS
6.2.1 LESS COMPREHENSIVE COVERAGE OF EXONS
6.2.2 CYBER SECURITY CONCERNS IN GENOMICS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER
6.3.2 INCREASING PRODUCT LAUNCHES IN RECENT YEARS
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 ETHICAL AND LEGAL ISSUES RELATED TO WHOLE EXOME SEQUENCING
7 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SECOND-GENERATION SEQUENCING
7.2.1 SEQUENCING BY SYNTHESIS (SBS)
7.2.2 SEQUENCING BY HYBRIDIZATION (SBH) AND SEQUENCING BY LIGATION (SBL)
7.3 THIRD-GENERATION SEQUENCING
8 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE
8.1 OVERVIEW
8.2 SYSTEMS
8.2.1 HISEQ SERIES
8.2.1.1 HISEQ 2500
8.2.1.2 HISEQ 1500
8.2.2 MISEQ SERIES
8.2.3 ION TORRENT PLATFORMS
8.2.3.1 ION PROTON
8.2.3.2 ION PGM
8.2.4 OTHERS
8.3 KITS
8.3.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS
8.3.2 LIBRARY PREPARATION KITS
8.3.3 TARGET ENRICHMENT KITS
8.3.4 OTHERS
8.4 SERVICES
8.4.1 SEQUENCING SERVICES
8.4.2 DATA ANALYSIS (BIOINFORMATICS) SERVICES
8.4.3 OTHERS
9 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISCOVERY AND DEVELOPMENT
9.3 AGRICULTURE & ANIMAL RESEARCH
9.4 DIAGNOSTICS
9.5 PERSONALIZED MEDICINE
9.6 OTHERS
10 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 ACADEMIC & RESEARCH INSTITUTES
10.4 HOSPITALS AND CLINICS
10.5 CLINICAL LABORATORIES
10.6 OTHERS
11 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TRADE
11.3 RETAIL SALES
11.4 OTHERS
12 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 COMPANY PROFILE
14.1 PERKINELMER GENOMICS (A SUBSIDIARY OF PERKINELMER INC.)
14.1.1 COMPANY SNAPSHOT
14.1.2 PRODUCT PORTFOLIO
14.1.3 RECENT DEVELOPMENTS
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 EXODX (A PART OF BIO-TECHNE)
14.3.1 COMPANY SNAPSHOT
14.3.2 PRODUCT PORTFOLIO
14.3.3 RECENT DEVELOPMENTS
14.4 THERMO FISHER SCIENTIFIC INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 FOUNDATION MEDICINE, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENTS
14.6 AZENTA US, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 BECKMAN COULTER, INC
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 CD GENOMICS
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 EUROFINS SCIENTIFIC
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 GENEDX, LLC
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 GENEFIRST LIMITED.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 ILLUMINA, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.13 INTEGRATED DNA TECHNOLOGIES, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 MERIDIAN BIOSCIENCE, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENTS
14.15 PSOMAGEN
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENTS
14.16 QIAGEN
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.17 SOPHIA GENETICS
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 TWIST BIOSCIENCE
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 2 NORTH AMERICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 3 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 4 GLOBAL SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 5 GLOBAL HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 6 NORTH AMERICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 7 NORTH AMERICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 8 NORTH AMERICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 9 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION)
TABLE 10 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION)
TABLE 11 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION)
TABLE 12 U.S. WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 13 U.S. SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 14 U.S. WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 15 U.S. SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 16 U.S. HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 17 U.S. ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 18 U.S. KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 19 U.S. SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 20 U.S. WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION)
TABLE 21 U.S. WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION)
TABLE 22 U.S. WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION)
TABLE 23 CANADA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 24 CANADA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 25 CANADA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 26 CANADA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 27 CANADA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 28 CANADA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 29 CANADA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 30 CANADA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 31 CANADA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION)
TABLE 32 CANADA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION)
TABLE 33 CANADA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION)
TABLE 34 MEXICO WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 35 MEXICO SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION)
TABLE 36 MEXICO WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 37 MEXICO SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 38 MEXICO HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 39 MEXICO ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 40 MEXICO KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 41 MEXICO SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION)
TABLE 42 MEXICO WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION)
TABLE 43 MEXICO WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION)
TABLE 44 MEXICO WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION
FIGURE 10 INCREASE IN USE OF WES TECHNOLOGY FOR NEW SCIENTIFIC APPLICATIONS AND INCREASING THE PREFERENCE OF WES OVER WHOLE-GENOME SEQUENCING IS ITS LOW-COST SEQUENCING CAPABILITY IS EXPECTED TO DRIVE THE NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 11 THE COMPONENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET IN 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA WHOLE EXOME SEQUENCING MARKET
FIGURE 13 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022
FIGURE 14 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022-2029 (USD MILLION)
FIGURE 15 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, CAGR (2022-2029)
FIGURE 16 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 17 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2022
FIGURE 18 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2023-2030 (USD MILLION)
FIGURE 19 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, CAGR (2023-2030)
FIGURE 20 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 21 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2022
FIGURE 22 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 23 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 24 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2022
FIGURE 26 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 27 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 28 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, LIFELINE CURVE
FIGURE 29 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 30 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 31 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 32 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2022)
FIGURE 34 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022)
FIGURE 35 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 36 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 37 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2023-2030)
FIGURE 38 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2022 (%)
